Abstract:Background. Hepatocellular carcinoma (HCC) is one of the deadliest tumors. The majority of HCC is detected in the late stage, and the clinical results for HCC patients are poor. There is an urgent need to discover early diagnostic biomarkers and potential therapeutic targets for HCC.Methods. The GSE87630 and GSE112790 datasets from the Gene Expression Omnibus (GEO) database were downloaded to analyze the differentially expressed genes (DEGs) between HCC and normal tissues. R packages were used for Kyoto Encyclopedia of Genes and Genomes (KEGG) and Gene Ontology (GO) enrichment analyses of the DEGs. A Search Tool for Retrieval of Interacting Genes (STRING) database was used to develop a protein-protein interaction (PPI) network, and also cytoHubba, Molecular Complex Detection (MCODE), EMBL-EBI, CCLE, Gene Expression Profiling Interactive Analysis (GEPIA), and Oncomine analyses were performed to identify hub genes. Gene expression was verified with a third GEO dataset, GSE25097. The Cancer Genome Atlas (TCGA) database was used to explore the correlations between the hub genes and clinical indexes of HCC patients. The functions of the hub genes were enriched by gene set enrichment analysis (GSEA), and the biological significance of the hub genes was explored by real-time polymerase chain reaction (qRT-PCR), western blot, immunofluorescence, CCK-8, colony formation, Transwell and flow cytometry assays with loss-of-function experiments in vitro.Results. Centromere protein N (CENPN) was screened as a hub gene affecting HCC tumorigenesis. Evaluation by Cox regression showed that a high level of CENPN expression was an independent danger variable for poor prognosis of HCC. GSEA showed that high CENPN expression was linked to the following pathways: liver cancer subclass proliferation, cell cycle, p53 signaling pathway, Rb1 pathway, positive regulation of cell cycle G1/S phase transition, and DNA damage response signal transduction by p53 class moderators. Further cell experiments showed that knocking down CENPN expression decreased the proliferation and colony-forming abilities of HepG2 and Huh7 cells as well as Ki67 expression in these cell lines. The cell cycle was arrested in G1 phase, which is consistent with previous experiments on CENPN downregulation., but neither migration nor invasion were significantly affected. Western blot results revealed that the expression of p53, p27, p21, CDK4, cyclin D1, CDK2, cyclin E, pRb, E2F1 and c-myc decreased after CENPN knockdown, but there was no significant change in total Rb levels. In addition, CENPN-knockdown cells subjected to irradiation showed significantly enhanced of gamma-H2AX expression and reduced colony formation.Conclusion. CENPN functions as an oncogene in HCC and may be a therapeutic target and promising prognostic marker for HCC.

CENPA functions as a transcriptional regulator to promote hepatocellular carcinoma progression via cooperating with YY1

A Positive Feedback Loop of CENPU/E2F6/E2F1 Facilitates Proliferation and Metastasis Via Ubiquitination of E2F6 in Hepatocellular Carcinoma

Centromere protein F promotes progression of hepatocellular carcinoma through ERK and cell cycle-associated pathways

The Oncogenic Role of CENPA in Hepatocellular Carcinoma Development: Evidence from Bioinformatic Analysis.

Downregulation of CENPK Suppresses Hepatocellular Carcinoma Malignant Progression Through Regulating YAP1.

Centromere Protein N May Be A Novel Malignant Prognostic Biomarker For Hepatocellular Carcinoma

CENP-H Regulates the Cell Growth of Human Hepatocellular Carcinoma Cells Through the Mitochondrial Apoptotic Pathway.

Reduced Expression of CENP-E Contributes to the Development of Hepatocellular Carcinoma and is Associated with Adverse Clinical Features

Centromere Protein F (CENPF) Serves As a Potential Prognostic Biomarker and Target for Human Hepatocellular Carcinoma

Overexpression of centromere protein K (CENP-K) gene in hepatocellular carcinoma promote cell proliferation by activating AKT/TP53 signal pathway.

Upregulation of CENPM Promotes Hepatocarcinogenesis Through Mutiple Mechanisms.

CENPA promotes clear cell renal cell carcinoma progression and metastasis via Wnt/β-catenin signaling pathway

Yin Yang-1 suppresses differentiation of hepatocellular carcinoma cells through the downregulation of CCAAT/enhancer-binding protein alpha

ShRNA-targeted Centromere Protein A Inhibits Hepatocellular Carcinoma Growth.

Characterization of the oncogenic function of centromere protein F in hepatocellular carcinoma.

Immune Infiltration Related CENPI Associates with the Malignant Features and Drug Resistance of Lung Adenocarcinoma.

LncRNA PCNAP1 modulates hepatitis B virus replication and enhances tumor growth of liver cancer.

Integrated Pan-Cancer Analysis of Centromere Protein F and Experimental Verification of Its Role and Clinical Significance in Cholangiocarcinoma.

Centromere Protein F is Identified As a Novel Therapeutic Target by Genomics Profile and Contributing to the Progression of Pancreatic Cancer.

Overexpression of Cenp-H As A Novel Prognostic Biomarker for Human Hepatocellular Carcinoma Progression and Patient Survival

[Expression of Centromere Protein A in Hepatocellular Carcinoma].